PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders.
Ptc Therapeutics stock last closed at $75.14, up 0.58% from the previous day, and has increased 47.39% in one year. It has overperformed other stocks in the Biotechnology industry by 1.2 percentage points. Ptc Therapeutics stock is currently +74.04% from its 52-week low of $43.18, and -14.13% from its 52-week high of $87.50.
As of Jun 12, 2026, there are 82.95M PTCT shares outstanding. The market cap of PTCT is $6.23B. In the past 24 hours, 1.07M PTCT shares were traded.
How to Buy Ptc Therapeutics Stock
Not sure how to invest in Ptc Therapeutics stock? Here's how.
Choose where to buy Ptc Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Ptc Therapeutics stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit money your brokerage account: Choose your method of payment and add your information.
Research Ptc Therapeutics stock: The Ptc Therapeutics ticker symbol is PTCT. Is Ptc Therapeutics stock a good investment? Should you buy shares of PTCT? How do PTCT's underlying business fundamentals look? Do top analysts think Ptc Therapeutics is a good buy? Why has PTCT's stock price moved recently? (Hint: Our stock market research website can help you decide if PTCT is a good stock to buy).
Make your PTCT trade: Decide if you will purchase PTCT shares at the current market price or use a limit order to purchase PTCT stock at a given price.
Get the latest scoop on your PTCT investment: Create a watchlist to important updates regarding your position in Ptc Therapeutics stock.
Step 1: Choose where to buy Ptc Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy PTCT shares.
A brokerage account allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world financial markets: From Tech to Industrials, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal information so you are able to invest in PTCT stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Ptc Therapeutics stock
Once you have selected the best place to buy Ptc Therapeutics stock, it's crucial to research their stock before you buy, so you truly comprehend the risk as well as the opportunity.
Ptc Therapeutics stock at a glance
PTCT Price
$75.14
1w %
5.88%
1y %
47.39%
5y %
71.08%
P/E
-30.3x
P/B
-34.54x
P/S
7.5x
PEG
N/A
Revenue
$827.11M
Earnings
-$186.73M
Fore. Rev. Growth
25.07%
Fore. Earn. Growth
N/A
Market Cap
$6.23B
Next Earnings
Aug 6, 2026
Next Dividend
N/A
Ptc Therapeutics Due Diligence Score
WallStreetZen was designed to help part-time investors do better fundamental analysis in less time.
PTCT has $1.89B in cash and short term investments. This is sufficient to cover its annual cash burn of $226.28M.
PTCT has cash burn of 226282000. It has enough cash and short-term investments to cover this for at least one year.
There are more short-term assets than long-term liabilities on the PTCT balance sheet.
There are more short-term assets than short-term liabilities on the PTCT balance sheet.
Negative Health Checks:
Total PTCT debt is still negative.
PTCT profit margin has gone down from 33.6% to -22.6% in the past year.
PTCT debt to equity ratio of -16.9 is negative.
Is it a good time to buy PTCT stock, according to analysts?
Out of 8 Wall Street analysts who monitor PTCT, the consensus analyst rating on Ptc Therapeutics is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest PTCT Analyst Upgrades/Downgrades
Jeffrey Hung, a top 8% analyst from Morgan Stanley maintains PTCT with a strong buy rating and raises their PTCT price target from $90.00 to $92.00, on Feb 23, 2026.
Morgan Stanley's Jeffrey Hung raised their price target on Ptc Therapeutics (NASDAQ: PTCT) by 2.2% from $90 to $92 on 2026/02/23. The analyst maintained their Strong Buy rating on the stock.
PTC Therapeutics reported its Q4 and FY 2025 earnings.
Raising their price target, Hung said they "updated their model on actuals and management's earnings call commentary."
Tazeen Ahmad, a top 37% analyst from Bank of America maintains PTCT with a strong buy rating and lowers their PTCT price target from $97.00 to $93.00, on Feb 20, 2026.
Eliana Merle, a top 18% analyst from Barclays upgrades PTCT to a strong buy rating and raises their PTCT price target from $68.00 to $119.00, on Jan 28, 2026.
Last year, PTCT revenue was $827.11M. In the past five year, PTCT's revenue has grown by 13.95% per year. This was slower than the Biotechnology industry average of 32.07%.
No, Ptc Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your PTCT trade
You have two primary order types:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are usually sufficient.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a particular dollar amount, place a limit order.
Press the Open button and your broker will place the order.
If you want more assistance buying stocks on eToro, click the how to video below:
How much does it cost to buy one Ptc Therapeutics share?
As of Jun 12, 2026, it costs $75.14 to buy one share of Ptc Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.133 shares of PTCT.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.